Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound

Journal of Controlled Release

Volumn 161, Issue 2, 2012, Pages 317-327

  Grüll, Holger ^a,b   Langereis, Sander ^b  

^a EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b PHILIPS RESEARCH LABORATORIES   (Netherlands)

Author keywords

Drug delivery; Focused ultrasound; Hyperthermia; Image guidance; Magnetic resonance imaging; Temperature sensitive liposome

Indexed keywords

CANCER THERAPY; CHEMOTHERAPEUTIC DRUGS; CLINICAL TRANSLATION; CO-ENCAPSULATION; ELEVATED TEMPERATURE; FOCUSED ULTRASOUND; HEALTHY TISSUES; HIGH INTENSITY FOCUSED ULTRASOUND; HYPERTHERMIA; IMAGE GUIDANCES; IMAGE-GUIDED; INVASIVE TREATMENT; MRI CONTRAST AGENTS; MRI SYSTEMS; PATIENT BED; SOFT TISSUE; SPATIAL RESOLUTION; TECHNOLOGICAL CHALLENGES; TEMPERATURE FEEDBACK; TEMPERATURE INFORMATION; TEMPERATURE-INDUCED; TEMPERATURE-SENSITIVE; TEMPERATURE-TRIGGERED DRUG DELIVERIES; TREATMENT PLANNING; TUMOR TISSUES; TUMOR TREATMENT; ULTRASOUND TRANSDUCERS;

EMBEDDED SYSTEMS; LIPOSOMES; MAGNETIC RESONANCE IMAGING; PARAMAGNETISM; PATIENT TREATMENT; TUMORS; ULTRASONIC TESTING; ULTRASONIC TRANSDUCERS;

DRUG DELIVERY;

DOXORUBICIN; LIPOSOME; PHOSPHOLIPID; TEMPERATURE SENSITIVE LIPOSOME; UNCLASSIFIED DRUG;

CALIBRATION; CHEMICAL STRUCTURE; DIFFUSION; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TUMOR LEVEL; ENCAPSULATION; HIGH INTENSITY FOCUSED ULTRASOUND; HYPERTHERMIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACOKINETICS; PRIORITY JOURNAL; PROCESS DESIGN; REVIEW; WATER TRANSPORT;

ANIMALS; DRUG DELIVERY SYSTEMS; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; LIPOSOMES; MAGNETIC RESONANCE IMAGING; TEMPERATURE;

EID: 84862665188     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.04.041     Document Type: Review

References (106)

1. K. Strebhardt, A. Ullrich, Paul Ehrlich'smagic bullet concept: 100 years of progress, Nat. Rev. Cancer 8 (2008) 473-480.
2. A. Schroeder, D.A. Heller, M.M. Winslow, J.E. Dahlman, G.W. Pratt, R. Langer, T. Jacks, D.G. Anderson, Treating metastatic cancer with nanotechnology, Nat. Rev. Cancer 12 (2012) 39-50.
3. E. Liapi, J.-F.H. Geschwind, Chemoembolization for primary and metastatic liver cancer, Cancer J. 16 (2010) 156-162.
4. S.N. Goldberg, M. Ahmed, Minimally invasive image-guided therapies for hepatocellular carcinoma, J. Clin. Gastroenterol. 35 (2002) S115-S129.
5. B.J. Wood, R.T. Poon, M.R. Dreher, K.K. Ng, M. Eugeni, S. Dromi, Z. Neeman, K. Michael, C.D.V. Black, R. Prabhakar, S.K. Libutti, Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies, J. Vasc. Interv. Radiol. 23 (2012) 248.
6. R.T.P. Poon, N. Borys, Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer, Expert. Opin. Pharmacother. 10 (2009) 333-343.
7. J.E. Kennedy, High-intensity focused ultrasound in the treatment of solid tumours, Nat. Rev. Cancer 5 (2005) 321-327.
8. A. Szent-Györgyi, Chemical and biological effects of ultra-sonic radiation, Nature 131 (1933).
9. J.G. Lynn, R.L. Zwemer, A.J. Chick, The biological application of focused ultrasonic waves, Science 96 (1942) 119-120.
10. P.D. Wall, W.J. Fry, R. Stephens, D. Tucker, J.Y. Lettvin, Changes produced in the central nervous system by ultrasound, Science 114 (1951) 686-687.
11. W.J. Fry, J.W. Barnard, F.J. Fry, R.F. Krumins, J.F. Brennan, Ultrasonic lesions in the mammalian central nervous system, Science 122 (1955) 517-518.
12. F.J. Fry, H.W. Ades, W.J. Fry, Production of reversible changes in the central nervous system by ultrasound, Science 127 (1958) 83-84.
13. P.M. Harari, K.H. Hynynen, R.B. Roemer, D.P. Anhalt, D.S. Shimm, B. Stea, J.R. Cassady, Development of scanned focused ultrasound hyperthermia-clinical response evaluation, Int. J. Radiat. Oncol. Biol. Phys. 21 (1991) 831-840.
14. C.M.C. Tempany, N.J. McDannold, K. Hynynen, F.A. Jolesz, Focused ultrasound surgery in oncology: overview and principles, Radiology 259 (2011) 39-56.
15. S.P. Bao, B.D. Thrall, D.L. Miller, Transfection of a reporter plasmid into cultured cells by sonoporation in vitro, Ultrasound Med. Biol. 23 (1997) 953-959.
16. K.D. Watson, C.-Y. Lai, S. Qin, D.E. Kruse, Y.-C. Lin, J.W. Seo, R.D. Cardiff, L.M. Mahakian, J. Beegle, E.S. Ingham, F.-R. Curry, R.K. Reed, K.W. Ferrara, Ultrasound increases nanoparticle delivery by reducing intratumoral pressure and increasing transport in epithelial and epithelial-mesenchymal transition tumors, Cancer Res. 72 (2012) 1485.
17. V. Frenkel, Ultrasound mediated delivery of drugs and genes to solid tumors, Adv. Drug Deliv. Rev. 60 (2008) 1193-1208.
18. S. Mitragotri, Innovation-healing sound: the use of ultrasound in drug delivery and other therapeutic applications, Nat. Rev. Drug Discov. 4 (2005) 255-260.
19. M.R. Böhmer, A.L. Klibanov, K. Tiemann, C.S. Hall, H. Grüll, O.C. Steinbach, Ultrasound triggered image-guided drug delivery, Eur. J. Radiol. 70 (2009) 242-253.
20. P.G. Sanches, H. Grüll, O.C. Steinbach, See, reach, treat: ultrasound-triggered image-guided drug delivery, Ther. Deliv. 2 (2011) 919-934.
21. R. Deckers, C.T.W. Moonen, Ultrasound triggered, image guided, local drug delivery, J. Control. Release 148 (2010) 25-33.
22. S.A. Sapareto, W.C. Dewey, Thermal dose determination in cancer therapy, Int. J. Radiat. Oncol. Biol. Phys. 10 (1984) 787-800.
23. N.J. McDannold, R.L. King, F.A. Jolesz, K.H. Hynynen, Usefulness of MR imaging-derived thermometry and dosimetry in determining the threshold for tissue damage induced by thermal surgery in rabbits, Radiology 216 (2000) 517-523.
24. F.A. Jolesz, N. McDannold, Current status and future potential of MRI-guided focused ultrasound surgery, J. Magn. Reson. Imaging 27 (2008) 391-399.
25. K. Hynynen, MRI-guided focused ultrasound treatments, Ultrasonics 50 (2010) 221-229.
26. P.S. Yarmolenko, E.J. Moon, C. Landon, A. Manzoor, D.W. Hochman, B.L. Viglianti, M.W. Dewhirst, Thresholds for thermal damage to normal tissues: an update, Int. J. Hyperthermia 27 (2011) 320-343.
27. G. Ter Haar, C. Coussios, High intensity focused ultrasound: physical principles and devices, Int. J. Hyperthermia 23 (2007) 89-104.
28. K. Hynynen, A. Darkazanli, E. Unger, J.F. Schenck, MRI-guided noninvasive ultrasound surgery, Med. Phys. 20 (1993) 107-115.
29. H.E. Cline, K. Hynynen, C.J. Hardy, R.D. Watkins, J.F. Schenck, F.A. Jolesz, MR temperature mapping of focused ultrasound surgery, Magn. Reson. Med. 31 (1994) 628-636.
30. B. Quesson, J.A. de Zwart, C.T.W. Moonen, Magnetic resonance temperature imaging for guidance of thermotherapy, J. Magn. Reson. Imaging 12 (2000) 525-533.
31. M.O. Köhler, C. Mougenot, B. Quesson, J. Enholm, B. Le Bail, C. Laurent, C.T.W. Moonen, G.J. Ehnholm, Volumetric HIFU ablation under 3D guidance of rapid MRI thermometry, Med. Phys. 36 (2009) 3521-3535.
32. J.K. Enholm, M.O. Köhler, B. Quesson, C. Mougenot, C.T. Moonen, S.D. Sokka, Improved volumetric MR-HIFU ablation by robust binary feedback control, IEEE Trans. Biomed. Eng. 57 (2010) 103-113.
33. C. Mougenot, M.O. Kohler, J. Enholm, B. Quesson, C. Moonen, Quantification of near-field heating during volumetric MR-HIFU ablation, Med. Phys. 38 (2011) 272-282.
34. M.J. Voogt, H. Trillaud, Y.S. Kim, W.P.T.M. Mali, J. Barkhausen, L.W. Bartels, R. Deckers, N. Frulio, H. Rhim, H.K. Lim, T. Eckey, H.J. Nieminen, C. Mougenot, B. Keserci, J. Soini, T. Vaara, M.O. Kohler, S. Sokka, M.A.A.J. van den Bosch, Volumetric feedback ablation of uterine fibroids usingmagnetic resonance-guided high intensity focused ultrasound therapy, Eur. Radiol. 22 (2012) 411-417.
35. C.M.C. Tempany, E.A. Stewart, N. McDannold, B.J. Quade, F.A. Jolesz, K. Hynynen, MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study, Radiology 226 (2003) 897-905.
36. N.M. Hijnen, E. Heijman, M.O. Köhler, M. Ylihautala, G.J. Ehnholm, A.W. Simonetti, H. Grüll, Tumour hyperthermia and ablation in rats using a clinical MR-HIFU system equipped with a dedicated small animal set-up, Int. J. Hyperthermia 28 (2) (2012) 141-155.
37. M. de Smet, E. Heijman, S. Langereis, N.M. Hijnen, H. Grüll, Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study, J. Control. Release 150 (2011) 102-110.
38. A.H. Negussie, P.S. Yarmolenko, A. Partanen, A. Ranjan, G. Jacobs, D. Woods, H. Bryant, D. Thomasson, M.W. Dewhirst, B.J. Wood, M.R. Dreher, Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound, Int. J. Hyperthermia 27 (2011) 140-155.
39. B. Hildebrandt, P. Wust, O. Ahlers, A. Dieing, G. Sreenivasa, T. Kerner, R. Felix, H. Riess, The cellular and molecular basis of hyperthermia, Crit. Rev. Oncol. Hematol. 43 (2002) 33-56.
40. M.B. Yatvin, J.N. Weinstein, W.H. Dennis, R. Blumenthal, Design of liposomes for enhanced local release of drugs by hyperthermia, Science 202 (1978) 1290-1293.
41. J.N. Weinstein, R.L. Magin, M.B. Yatvin, D.S. Zaharko, Liposomes and local hyperthermia-selective delivery of methotrexate to heated tumors, Science 204 (1979) 188-191.
42. E. Evans, D. Needham, Physical-properties of surfactant bilayer-membranes-thermal transitions, elasticity, rigidity, cohesion, and colloidal interactions, J. Phys. Chem. 91 (1987) 4219-4228.
43. G.R. Anyarambhatla, D. Needham, Enhancement of the phase transition permeability of DPPC liposomes by incorporation of MPPC: a new temperature-sensitive liposome for use with mild hyperthermia, J. Liposome Res. 9 (1999) 491-506.
44. G. Leidy, W.F. Wolkers, K. Jorgensen, O.G. Mouritsen, J.H. Crowe, Lateral organization and domain formation in a two-component lipid membrane system, Biophys. J. 80 (2001) 1819-1828.
45. S.L. Veatch, S.L. Keller, Seeing spots: complex phase behavior in simple membranes, Biochim. Biophys. Acta, Mol. Cell. Res. 1746 (2005) 172-185.
46. G. Kong, G. Anyarambhatla, W.P. Petros, R.D. Braun, O.M. Colvin, D. Needham, M.W. Dewhirst, Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release, Cancer Res. 60 (2000) 6950-6957.
47. B.L. Viglianti, A.M. Ponce, C.R. Michelich, D. Yu, S.A. Abraham, L. Sanders, P.S. Yarmolenko, T. Schroeder, J.R. MacFall, D.P. Barboriak, O.M. Colvin, M.B. Bally, M.W. Dewhirst, Chemodosimetry of in vivo tumor liposomal drug concentration using MRI, Magn. Reson. Med. 56 (2006) 1011-1018.
48. M. de Smet, S. Langereis, S. van den Bosch, H. Grüll, Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance, J. Control. Release 143 (2010) 120-127.
49. T. Tagami, W.D. Foltz, M.J. Ernsting, C.M. Lee, I.F. Tannock, J.P. May, S.-D. Li, MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome, Biomaterials 32 (2011) 6570-6578.
50. A.D. Bangham, R.W. Horne, Negative staining of phospholipids + their structural modifications by surface active agents as observed in electron microscope, J. Mol. Biol. 8 (1964) 660-668.
51. D.C. Drummond, C.O. Noble, M.E. Hayes, J.W. Park, D.B. Kirpotin, Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development, J. Pharm. Sci. 97 (2008) 4696-4740.
52. H.I. Chang, M.K. Yeh, Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy, Int. J. Nanomedicine 7 (2012) 49-60.
53. R.D. Hofheinz, S.U. Gnad-Vogt, U. Beyer, A. Hochhaus, Liposomal encapsulated anti-cancer drugs, Anticancer Drugs 16 (2005) 691-707.
54. W.J.M. Mulder, G.J. Strijkers, G.A.F. van Tilborg, A.W. Griffioen, K. Nicolay, Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging, NMR Biomed. 19 (2006) 142-164.
55. S. Hak, H. Sanders, P. Agrawal, S. Langereis, H. Grüll, H.M. Keizer, F. Arena, E. Terreno, G.J. Strijkers, K. Nicolay, A high relaxivity Gd(III)DOTA-DSPE-based liposomal contrast agent for magnetic resonance imaging, Eur. J. Pharm. Biopharm. 72 (2009) 397-404.
56. Y. Matsumura, H. Maeda, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs, Cancer Res. 46 (1986) 6387-6392.
57. A.L. Klibanov, K. Maruyama, V.P. Torchilin, L. Huang, Amphiphatic polyethyleneglycols effectively prolong the circulation time of liposomes, FEBS Lett. 268 (1990) 235-237.
58. A.L. Klibanov, L. Huang, Long circulating liposomes development and perspectives, J. Liposome Res. 2 (1992) 321-334.
59. H. Maeda, Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects, Bioconjug. Chem. 21 (2010) 797-802.
60. D.C. Drummond, O. Meyer, K.L. Hong, D.B. Kirpotin, D. Papahadjopoulos, Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors, Pharmacol. Rev. 51 (1999) 691-743.
61. K.M. Laginha, S. Verwoert, G.J.R. Charrois, T.M. Allen, Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors, Clin. Cancer Res. 11 (2005) 6944-6949.
62. S.C. White, P. Lorigan, G.P. Margison, J.M. Margison, F. Martin, N. Thatcher, H. Anderson, M. Ranson, Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer, Br. J. Cancer 95 (2006) 822-828.
63. D. Papahadjopoulos, K. Jacobson, S. Nir, T. Isac, Phase transitions in phospholipid vesicles-fluorescence polarization and permeability measurements concerning effect of temperature and cholesterol, Biochim. Biophys. Acta 311 (1973) 330-348.
64. L. Cruzeir-Hansson, O.G. Mouritsen, Passive ion permeability of lipid membranes modeled via lipid domain interfacial area, Biochim. Biophys. Acta 944 (1988) 63-72.
65. A. Blume, Comparative study of the phase-transitions of phospholipid bilayers and monolayers, Biochim. Biophys. Acta 557 (1979) 32-44.
66. M.J. Ruocco, D.J. Siminovitch, R.G. Griffin, Comparative study of the gel phases of ether-linked and ester-linked phosphatidylcholines, Biochemistry (Mosc) 24 (1985) 2406-2411.
67. S. Mabrey, J.M. Sturtevant, Investigation of phase-transitions of lipids and lipid mixtures by high sensitivity differential scanning calorimetry, Proc. Natl. Acad. Sci. U. S. A. 73 (1976) 3862-3866.
68. D. Needham, G. Anyarambhatla, G. Kong, M.W. Dewhirst, A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model, Cancer Res. 60 (2000) 1197-1201.
69. D.L. Bratton, R.A. Harris, K.L. Clay, P.M. Henson, Effects of platelet activating factor and related lipids on phase-transition of dipalmitoylphosphatidylcholine, Biochim. Biophys. Acta 941 (1988) 76-82.
70. D. Needham, M.W. Dewhirst, The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors, Adv. Drug Deliv. Rev. 53 (2001) 285-305.
71. B. Banno, L.M. Ickenstein, G.N.C. Chiu, M.B. Bally, J. Thewalt, E. Brief, E.K. Wasan, The functional roles of poly(ethylene glycol)-lipid and lysolipid in the drug retention and release from lysolipid-containing thermosensitive liposomes in vitro and in vivo, J. Pharm. Sci. 99 (2009) 2295-2308.
72. L.M. Ickenstein, M.C. Arfvidsson, D. Needham, L.D. Mayer, K. Edwards, Disc formation in cholesterol-free liposomes during phase transition, Biochim. Biophys. Acta, Biomembr. 1614 (2003) 135-138.
73. D. Chelsea, C.D. Landon, J.-Y. Park, D. Needham, M.W. Dewhirst, Nanoscale drug delivery and hyperthermia: the materials design and preclinical and clinical testing of low temperature-sensitive liposomes used in combination with mild hyperthermia in the treatment of local cancer, Open Nanomed. J. 3 (2011) 38-64.
74. A. Gasselhuber, M.R. Dreher, A. Negussie, B.J. Wood, F. Rattay, D. Haemmerich, Mathematical spatio-temporal model of drug delivery from low temperature sensitive liposomes during radiofrequency tumour ablation, Int. J. Hyperthermia 26 (2010) 499-513.
75. M.C. Sandström, L.M. Ickenstein, L.D. Mayer, K. Edwards, Effects of lipid segregation and lysolipid dissociation on drug release from thermosensitive liposomes, J. Control. Release 107 (2005) 131-142.
76. T. Tagami, M.J. Ernsting, S.-D. Li, Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system, J. Control. Release 154 (2011) 290-297.
77. T. Tagami, M.J. Ernsting, S.-D. Li, Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin, J. Control. Release 152 (2011) 303-309.
78. L.H. Lindner, M.E. Eichhorn, H. Eibl, N. Teichert, M. Schmitt-Sody, R.D. Issels, M. Dellian, Novel temperature-sensitive liposomes with prolonged circulation time, Clin. Cancer Res. 10 (2004) 2168-2178.
79. M. Hossann, M. Wiggenhorn, A. Schwerdt, K. Wachholz, N. Teichert, H. Eibl, R.D. Issels, L.H. Lindner, In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes, Biochim. Biophys. Acta 1768 (2007) 2491-2499.
80. L.H. Lindner, M. Hossann, M. Vogeser, N. Teichert, K. Wachholz, H. Eibl, W. Hiddemann, R.D. Issels, Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug release, J. Control. Release 125 (2008) 112-120.
81. M. Hossann, T. Wang, M. Wiggenhorn, R. Schmidt, A. Zengerle, G. Winter, H. Eibl, M. Peller, M. Reiser, R.D. Issels, L.H. Lindner, Size of thermosensitive liposomes influences content release, J. Control. Release 147 (2010) 436-443.
82. V.J. Caride, H.D. Sostman, R.D. Winchell, J.C. Core, Relaxation enhancement using liposomes carrying paramagnetic species, Magn. Reson. Imaging 2 (1984) 107-112.
83. G. Bacic, M.R. Niesman, H.F. Bennett, R.L. Magin, H.M. Swartz, Modulation of water proton relaxation rates by liposomes containing paramagnetic materials, Magn. Reson. Med. 6 (1988) 445-458.
84. S.L. Fossheim, A.K. Fahlvik, J. Klaveness, R.N. Muller Paramagnetic, liposomes as MRI contrast agents: influence of liposomal physicochemical properties on the in vitro relaxivity, Magn. Reson. Imaging 17 (1999) 83-89.
85. S.L. Fossheim, K.A. Il'yasov, J. Hennig, A. Bjørnerud, Thermosensitive paramagnetic liposomes for temperature control during MR Imaging-guided hyperthermia: in vitro feasibility studies, Acad. Radiol. 7 (2000) 1107-1115.
86. J.A. de Zwart, R. Salomir, F. Vimeux, J. Klaveness, C.T.W. Moonen, On the feasibility of local drug delivery using thermo-sensitive liposomes and MR-guided focused ultrasound, Proc. Int. Soc. Magn. Reson. Med. 8 (2000) 43.
87. R. Salomir, J. Palussière, S.L. Fossheim, A. Rogstad, U.N. Wiggen, N. Grenier, C.T.W. Moonen, Local delivery of Magnetic Resonance (MR) contrast agent in kidney using thermosensitive liposomes and MR Imaging-guided local hyperthermia: a feasibility study in vivo, J. Magn. Reson. Imaging 22 (2005) 534-540.
88. N. McDannold, S.L. Fossheim, H. Rasmussen, H. Martin, N. Vykhodtseva, K. Hynynen, Heat-activated liposomal MR contrast agent: initial in vivo results in rabbit liver and kidney, Radiology 230 (2004) 743-752.
89. S. Langereis, J. Keupp, J.L.J. van Veldhoven, I.H.C. de Roos, D. Burdinski, J.A. Pikkemaat, H. Grüll, A temperature-sensitive liposomal 1H CEST and 19F contrast agent for MR Image-guided drug delivery, J. Am. Chem. Soc. 131 (2009) 1380-1381.
90. A.M. Ponce, B.L. Viglianti, D. Yu, P.S. Yarmolenko, C.R. Michelich, J. Woo, M.B. Bally, M.W. Dewhirst, Magnetic Resonance Imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects, J. Natl. Cancer Inst. 99 (2007) 53-63.
91. S.A. Abraham, K. Edwards, G. Karlsson, S. MacIntosh, L.D. Mayer, C. McKenzie, M.B. Bally, Formation of transition metal-doxorubicin complexes inside liposomes, Biochim. Biophys. Acta 1565 (2002) 41-54.
92. S. Aime, D.D. Castelli, E. Terreno, Highly sensitive MRI chemical exchange saturation transfer agents using liposomes, Angew. Chem. Int. Ed. 44 (2005) 5513-5515.
93. E. Terreno, C. Cabella, C. Carrera, D. Delli Castelli, R. Mazzon, S. Rollet, J. Stancanello, M. Visigalli, S. Aime, From spherical to osmotically shrunken paramagnetic liposomes: an improved generation of LIPOCEST MRI agents with highly shifted water protons, Angew. Chem. Int. Ed. 46 (2007) 966-968.
94. J.Y. Zhou, P.C.M. van Zijl, Chemical exchange saturation transfer imaging and spectroscopy, Prog. Nucl. Magn. Reson. Spectrosc. 48 (2006) 109-136.
95. E. Terreno, D.D. Castelli, A. Viale, S. Aime, Challenges for molecular magnetic resonance imaging, Chem. Rev. 110 (2010) 3019-3042.
96. S. Viswanathan, Z. Kovacs, K.N. Green, S.J. Ratnakar, A.D. Sherry, Alternatives to gadolinium-based metal chelates for magnetic resonance imaging, Chem. Rev. 110 (2010) 2960-3018.
97. D. Burdinski, J.A. Pikkemaat, M. Emrullahoglu, F. Costantini, W. Verboom, S. Langereis, H. Grull, J. Huskens, Targeted LipoCEST contrast agents for magnetic resonance imaging: alignment of aspherical liposomes on a capillary surface, Angew. Chem. Int. Ed. 49 (2010) 2227-2229.
98. S. Dromi, V. Frenkel, A. Luk, B. Traughber, M. Angstadt, M. Bur, J. Poff, J. Xie, S.K. Libutti, K.C.P. Li, B.J. Wood, Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect, Clin. Cancer Res. 13 (2007) 2722-2727.
99. R. Staruch, R. Chopra, K. Hynynen, Localised drug release using MRI-controlled focused ultrasound hyperthermia, Int. J. Hyperthermia 27 (2011) 156-171.
100. Ashish Ranjan, Genevieve C. Jacobs, David L. Woods, Ayele H. Negussie, Ari Partanen, Pavel S. Yarmolenko, Carmen E. Gacchina, Karun V. Sharma, Victor Frenkel, Bradford J. Woods, Matthew R. Dreher, Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model, J. Control. Release 158 (3) (March 28 2012) 487-494.
101. R. Staruch, R. Chopra, K. Hynynen, Hyperthermia in bone generated with MR imaging-controlled focused ultrasound: control strategies and drug delivery, Radiology 263 (2012) 117-127.
102. P.R. Patel, A. Luk, A. Durrani, S. Dromi, J. Cuesta, M. Angstadt, M.R. Dreher, B.J. Wood, V. Frenkel, In vitro and in vivo evaluations of increased effective beam width for heat deposition using a split focus high intensity ultrasound (HIFU) transducer, Int. J. Hyperthermia 24 (2008) 537-549.
103. B.D. Weinberg, R.B. Patel, A.A. Exner, G.A. Saidel, J.M. Gao, Modeling doxorubicin transport to improve intratumoral drug delivery to RF ablated tumors, J. Control. Release 124 (2007) 11-19.
104. Y. Matsumura, H. Maeda, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs, Cancer Res. 46 (1986) 6387-6392.
105. A. Yudina, M. de Smet, M. Lepetit-Coiffe, S. Langereis, L. Van Ruijssevelt, P. Smirnov, V. Bouchaud, P. Voisin, H. Grüll, C.T.W. Moonen, Ultrasound-mediated intracellular drug delivery using microbubbles and temperature-sensitive liposomes, J. Control. Release 155 (2011) 442-448.
106. Anna Yudina, Matthieu Lepetit-Coiffé, Mariska De Smet, Sander Langereis, Holger Grüll, Chrit Moonen, In vivo temperature controlled ultrasound-mediated intracellular delivery of cell-impermeable compounds, J. Controll. Release (in press), Available online 18 April 2012.